Views
1 year ago

gwpfdb7

gwpfdb7

Healthcare Ready,

Healthcare Ready, formerly known as Rx Response, helps to strengthen health care supply chains through collaboration with public health and private sectors by addressing pressing issues before, during, and after disasters. As the convener of industry and government, Healthcare Ready safeguards patient health by offering solutions to critical problems and providing best practices to facilitate health care preparedness and response. Since its inception in the aftermath of hurricane Katrina over a decade ago, Healthcare Ready has helped companies, government agencies, and other organizations quickly and effectively address health care supply chain concerns before, during, and after disasters. In addition, Healthcare Ready offers Rx Open, an online resource that maps the location of open pharmacies in disaster-stricken areas. Please visit www.healthcareready.org for more information. 42 Impact on the Economy and Biomedical Ecosystem

REFERENCES 1 Battelle Technology Partnership Practice. The economic impact of the biopharmaceutical industry. Published July 2013. 2 Pharmaceutical Research and Manufacturers of America (PhRMA). PhRMA Annual Membership Survey, 1995-2015. Washington, DC: PhRMA; 2016. 3 Burrill & Company. Analysis for PhRMA. January 31, 2012. 4 PhRMA analysis of National Science Foundation, Business Research, Development, and Innovation Survey (BRDIS) 2011, 2014. 5 NDP Analytics. IP-intensive manufacturing industries: Driving U.S. economic growth. http://www.ndpanalytics.com/ip-intensivemanufacturing-industries-driving-us-economic-growth-2015/. Published March 2015. Accessed March 2016. And The innovative pharmaceutical manufacturing industry: Driving economic growth. http://static1.squarespace.com/static/52850a5ce4b068394a270176/t/5 50988aae4b0c8ba828b7d93/1426688170846/IP+Pharma+Report+March+2015.pdf. Published March 2015. Accessed March 2016. 6 TEConomy Partners. The economic impact of the U.S. biopharmaceutical industry. April 2016. 7 PhRMA analysis of US Department of Commerce, International Trade Administration. TradeStats Express: National Trade Data. http:// tse.export.gov/TSE/TSEhome.aspx. Accessed March 2016. 8 NDP Analytics. IP-intensive manufacturing industries: Driving U.S. economic growth. http://www.ndpanalytics.com/ip-intensivemanufacturing-industries-driving-us-economic-growth-2015/. Published March 2015. Accessed March 2016. And The innovative pharmaceutical manufacturing industry: Driving economic growth. http://static1.squarespace.com/static/52850a5ce4b068394a270176/t/5 50988aae4b0c8ba828b7d93/1426688170846/IP+Pharma+Report+March+2015.pdf. Published March 2015. Accessed March 2016. 9 NDP Analytics. IP-intensive manufacturing industries: Driving U.S. economic growth. http://www.ndpanalytics.com/ip-intensivemanufacturing-industries-driving-us-economic-growth-2015/. Published March 2015. Accessed March 2016. And The innovative pharmaceutical manufacturing industry: Driving economic growth. http://static1.squarespace.com/static/52850a5ce4b068394a270176/t/5 50988aae4b0c8ba828b7d93/1426688170846/IP+Pharma+Report+March+2015.pdf. Published March 2015. Accessed March 2016. 10 PhRMA analysis of National Science Foundation (NSF), National Center for Science and Engineering Statistics. USPTO patents granted in pharmaceuticals, by region/country/economy: Selected years, 1998–2014. Arlington, VA: NSF; 2016. http://www.nsf.gov/statistics/2016/ nsb20161/uploads/1/9/at06-50.pdf. Accessed March 2016. 11 NDP Analytics. IP-intensive manufacturing industries: Driving U.S. economic growth. http://www.ndpanalytics.com/ip-intensivemanufacturing-industries-driving-us-economic-growth-2015/. Published March 2015. Accessed March 2016. And The innovative pharmaceutical manufacturing industry: Driving economic growth. http://static1.squarespace.com/static/52850a5ce4b068394a270176/t/5 50988aae4b0c8ba828b7d93/1426688170846/IP+Pharma+Report+March+2015.pdf. Published March 2015. Accessed March 2016. 12 U.S. Department of Labor. The STEM workforce challenge: The role of the public workforce system in a national solution for a competitive science, technology, engineering, and mathematics (STEM) workforce. https://www.doleta.gov/youth_services/pdf/STEM_ Report_4%2007.pdf. Published April 2007. Accessed March 2016. 13 National Science Foundation. Worldwide, domestic, and foreign all and R&D employment, by industry and company size: 2010, 2014. 14 Getz KA. Sizing up the clinical research market. Appl. Clin. Trials. 2010;19(3):32-34. 15 TEConomy Partners. Forthcoming Report. 16 Battelle Technology Partnership Practice. Biopharmaceutical industry-sponsored clinical trials: impact on state economies. Report prepared for PhRMA. February 2015. 17 PhRMA analysis of National Venture Capital Association and PwC. 2015 MoneyTree Report. http://nvca.org/research/ventureinvestment/. Published January 2016. Accessed March 2016. 18 PhRMA analysis of National Venture Capital Association and PwC. 2015 MoneyTree Report. http://nvca.org/research/ventureinvestment/. Published January 2016. Accessed March 2016. 19 PhRMA analysis of National Venture Capital Association and PwC. 2015 MoneyTree Report. http://nvca.org/research/ventureinvestment/. Published January 2016. Accessed March 2016. Impact on the Economy and Biomedical Ecosystem 43

PHOTO TO BE INSERTED
I've Got Nothing to Lose by Trying It - Sense About Science
220-Dictionary of Pharmaceutical Medicine, 2nd Edition-Gerhard Nahler Annette Mollet-3211898352-S
Pharma 2020: Virtual R&D Which path will you take? - PwC
Providing Value to Patients and Society - Cecodes
Keys to Improving Access & Innovation of Needed Medicines
NPC Brochure - National Pharmaceutical Council
WHO-Medicines-Report-FINAL2015
Fiction?
Adaptive Designs in Clinical Drug Development ... - Biopharmnet.com
“Drugs don’t work in patients who don’t take
Overview of ART history and Trials - Jane Crawley - EuroCoord